Joseph D. Szustakowski
Bristol-Myers Squibb (United States) · 72 works · 11,436 citations · h-index 29
Top works
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
- Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
- Plasma proteomic associations with genetics and health in the UK Biobank
- DeconRNASeq: a statistical framework for deconvolution of heterogeneous tissue samples based on mRNA-Seq data
- First-Line Nivolumab Plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers
- Optimal Deconvolution of Transcriptional Profiling Data Using Quadratic Programming with Application to Complex Clinical Blood Samples
- Whole‐Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis
- Computational Identification of Operons in Microbial Genomes
- Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank
- Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
- Protein structure alignment using a genetic algorithm
- Abstract CT078: Tumor mutational burden (TMB) as a biomarker for clinical benefit from dual immune checkpoint blockade with nivolumab (nivo) + ipilimumab (ipi) in first-line (1L) non-small cell lung cancer (NSCLC): identification of TMB cutoff from CheckMate 568
- STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort
- Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors
- Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
- LMX1B Mutations Cause Hereditary FSGS without Extrarenal Involvement
- Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals
- Estrogen-related receptor α is essential for the expression of antioxidant protection genes and mitochondrial function
- Duplicated Enhancer Region Increases Expression of CTSB and Segregates with Keratolytic Winter Erythema in South African and Norwegian Families